Haluska, P., Worden, F., Olmos, D., Yin, D., Schteingart, D., Batzel, G. N., . . . Hammer, G. D. (2009). Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma.
Trích dẫn kiểu ChicagoHaluska, Paul, et al. Safety, Tolerability, and Pharmacokinetics of the Anti-IGF-1R Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma. 2009.
Trích dẫn MLAHaluska, Paul, et al. Safety, Tolerability, and Pharmacokinetics of the Anti-IGF-1R Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma. 2009.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.